PulseAugur
EN
LIVE 00:01:24
中文(ZH) ST中珠：股东拟减持不超3%公司股份

ST中珠股东拟减持不超过3%股份，维康药业感冒清热颗粒中选集采

By PulseAugur Editorial · [1 sources] ·

ST中珠 announced that one of its shareholders, Shenzhen Zhongshengyuan Enterprise Management Center (Limited Partnership), plans to reduce its stake by up to 3% of the company's total share capital due to its own capital needs. This reduction will be carried out through centralized bidding and block trading methods. Separately, Weikang Pharmaceutical announced that its product Ganmao Qingre Granules has been selected for a national centralized procurement of traditional Chinese medicine. AI

RANK_REASON The item is a digest of unrelated news items, with no single dominant AI-related story.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

ST中珠股东拟减持不超过3%股份，维康药业感冒清热颗粒中选集采

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Meme
The item is a digest of unrelated news items, with no single dominant AI-related story.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
110 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    ST Zhongzhu: Shareholders Plan to Reduce Holdings by No More Than 3% of Company Shares

    36氪获悉，ST中珠公告，股东深圳市中盛源企业管理中心（有限合伙）因自身资金需求，拟通过集中竞价和大宗交易方式减持所持有的不超过5978.61万股公司股票，占公司总股本比例不超过3%。

RELATED ENTITIES

RELATED TOPICS